Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 4Recruiting 3Active not recruiting 3Unknown 2Withdrawn 1Terminated 1

Sponsor Class

NETWORK 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Leukemia 37Lymphoma 12Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 4Leukemia, Biphenotypic, Acute 4Burkitt Lymphoma 4Neoplasm, Residual 3Myelodysplastic Syndromes 3Dendritic Cell Sarcoma, Interdigitating 3Anemia, Refractory, with Excess of Blasts 3Recurrence 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Extranodal NK-T-Cell 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Monocytic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Anemia, Refractory 2Thrombocytopenia 1Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neoplasms 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 29fludarabine phosphate 19Filgrastim 18Whole-Body Irradiation 15Mycophenolic Acid 15Methotrexate 15Peripheral Blood Stem Cell Transplantation 14Cytarabine 14Cyclosporine 13Busulfan 12Methylprednisolone 10Thiotepa 9Antilymphocyte Serum 9Tacrolimus 8Granulocyte Colony-Stimulating Factor 8Clofarabine 8Vincristine 7Radiotherapy 7Melphalan 7Cord Blood Stem Cell Transplantation 7fludarabine 6Leucovorin 6Dexamethasone 6merphos 5Mercaptopurine 5Etoposide 5Daunorubicin 5Cladribine 5Therapeutics 4Prednisone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Leukemia, Biphenotypic, Acute × Asparaginase × Clear all
NCT00557193 2024-07-15

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Completed
218 enrolled 21 charts
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00061945 2022-05-03

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed
302 enrolled 11 charts
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00022126 2014-02-20

Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 2 Completed
6 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002756 2014-02-14

Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 2 Completed
221 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡